Nasal vaccines for pertussis
Open Access
- 10 June 2023
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 84, 102355
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland
This publication has 42 references indexed in Scilit:
- IL-17–Producing Innate and Pathogen-Specific Tissue Resident Memory γδ T Cells Expand in the Lungs of Bordetella pertussis–Infected MiceThe Journal of Immunology, 2017
- Asymptomatic transmission and the resurgence of Bordetella pertussisBMC Medicine, 2015
- A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male VolunteersPLOS ONE, 2014
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate modelProceedings of the National Academy of Sciences, 2013
- Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primatesMucosal Immunology, 2013
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis VaccinePLOS Pathogens, 2013
- Comparative Role of Immunoglobulin A in Protective Immunity against the BordetellaeInfection and Immunity, 2007
- Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccineVaccine, 2000
- A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteersJournal of Medical Microbiology, 2000
- Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain GenesJournal of Experimental Medicine, 1997